Pathirana, D <br/><br/>
European S3-guidelines on the systemic treatment of psoriasis vulgaris.  [electronic resource] 

 -  Journal of the European Academy of Dermatology and Venereology : JEADV  Oct 2009 
 - 1-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3083 
<br/><br/><label>Standard No.: </label>10.1111/j.1468-3083.2009.03389.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Alefacept<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Cyclosporine--adverse effects<br/>Dermatologic Agents--adverse effects<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infliximab<br/>Methotrexate--adverse effects<br/>PUVA Therapy--adverse effects<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Recombinant Fusion Proteins--adverse effects<br/>Retinoids--adverse effects